Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer imaging compound for use in PET scans on patients with recurring prostate cancer. The stock jumped 4% in the ...
Photos of your pet are downloaded on the AI service's app and can determine: Eye problems: Cataracts and some other lens problems can be identified early. Ear canal problems: Inflammation can be ...